Irazu Oncology: Funding, Investors & Team (Sep 2026)
Our mission is to develop a superior vaccine platform to improve clinical outcomes for cancer patients
Irazu Oncology has raised $3.1M across 2 funding rounds on record, the most recent a Seed of $500k announced in Mar 2025.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Irazu Oncology Company Profile and Key Stats
Latest funding round on record: Mar 2025.
Irazu Oncology Funding Rounds
Irazu Oncology raised $2.6M in an undisclosed round announced in Dec 2023.
1.3 years later, a Seed of $500k was announced in Mar 2025.
Irazu Oncology Founders and Leadership Team
Contact details for the Irazu Oncology team: 1 of 2 have an email address on file.
Start 14-day free trial →Irazu Oncology Funding Compared to Other Biotechnology Startups
Irazu Oncology's latest round of $500k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Irazu Oncology in Biotechnology and Baltimore
Companies Similar to Irazu Oncology
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Irazu Oncology Funding FAQs
What does Irazu Oncology do?
Our mission is to develop a superior vaccine platform to improve clinical outcomes for cancer patients
How much funding has Irazu Oncology raised?
Irazu Oncology has raised $3.1M across 2 rounds on record. The most recent is a Seed of $500k announced in Mar 2025.
When did Irazu Oncology last raise funding?
Irazu Oncology's most recent funding round on record is a Seed of $500k, announced in Mar 2025.
Who founded Irazu Oncology?
FundedIQ lists Brad Cawthern (Founder), Jeffrey Strovel (Founder) at Irazu Oncology.
Where is Irazu Oncology headquartered?
Irazu Oncology is based in Baltimore, Maryland, United States.
How many employees does Irazu Oncology have?
Irazu Oncology is in the 1-10 employee band.
How does Irazu Oncology's funding compare to other Biotechnology startups?
Irazu Oncology's latest round of $500k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Irazu Oncology Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Irazu Oncology is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.